Novo Nordisk announced that the Food and Drug Administration (FDA) has approved FlexPro PenMate, which is intended for patients who use Norditropin (somatropin [rDNA origin]) FlexPro 5mg, 10mg, and ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Norditropin® FlexPro® is a dial-a-dose pen containing the active ...
PRINCETON, N.J. The Food and Drug Administration has approved a Novo Nordisk treatment for growth hormone disorders, the Danish drug maker announced Wednesday. The agency approved Norditropin FlexPro ...
PLAINSBORO, N.J., July 16, 2015 /PRNewswire/ -- Novo Nordisk announced today the U.S. Food and Drug Administration (FDA) approval of FlexPro® PenMate®, designed for users of Norditropin® FlexPro® 5 mg ...
PRINCETON, N.J., Sept. 21 -- Novo Nordisk today announced that Norditropin(R) (somatropin [rDNA origin] injection) received approval from the U.S. Food and Drug Administration (FDA) for the treatment ...
NORDITROPIN NORDIFLEX PEN (Somatropin) 30mg/3mL injection by Novo Nordisk The Norditropin (somatropin [rDNA origin] injection) NordiFlex 30mg/3mL prefilled pen has been made available by Novo Nordisk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback